JLMED
ActiveSummary
JLMED has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €173,245 and a net result of €56,797. Equity is growing by about 49% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 27 days late
2025
31-12
Financial
Equity above €150,000equity €173,245 ▲48.8%
A profit in every financial year since 2023 builds equity to €173,245.
10-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2023 to 2025net €57,241 ▲1.8%
Net result €57,241, the highest in the series.
31-12
Financial
Equity above €100,000equity €116,448 ▲96.7%
A profit in every financial year since 2023 builds equity to €116,448.
03-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.